title: High-dose rosiglitazone is pro-atherogenic in cholesterol-fed rabbits.
authors.forename: Yanli
authors.initials: Y
authors.lastname: Wang
authors.forename: Fang
authors.initials: F
authors.lastname: Cheng
authors.forename: Yulong
authors.initials: Y
authors.lastname: Chen
authors.forename: Yafen
authors.initials: Y
authors.lastname: Li
authors.forename: Sihai
authors.initials: S
authors.lastname: Zhao
authors.forename: Qi
authors.initials: Q
authors.lastname: Yu
authors.forename: Jianglin
authors.initials: J
authors.lastname: Fan
authors.forename: Enqi
authors.initials: E
authors.lastname: Liu
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000473:pathology; D050197:Atherosclerosis / Q000139:chemically induced* / Q000473:pathology; D002791:Cholesterol, Dietary / Q000009:adverse effects*; D008297:Male; D011817:Rabbits; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D002791:Cholesterol, Dietary; D045162:Thiazolidinediones; D000077154:Rosiglitazone